© 2026 Western New York Public Broadcasting Association

140 Lower Terrace St.
Buffalo, NY 14202

Toronto Address:
130 Queens Quay E.
Suite 903
Toronto, ON M5A 0P6


Mailing Address:
Horizons Plaza P.O. Box 1263
Buffalo, NY 14240-1263

Buffalo Toronto Public Media | Phone 716-845-7000
BTPM NPR Newsroom | Phone: 716-845-7040
Differing shades of blue wavering throughout the image
Give Now
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why one doctor is 'cautiously hopeful' about GLP-1s for addiction treatment

WBUR | By Here & Now Newsroom
Published February 19, 2026 at 12:00 PM EST
The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (David J. Phillip/AP)
David J. Phillip/AP
The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (David J. Phillip/AP)

Here & Now‘s Peter O’Dowd speaks with addiction specialist Dr. Mark S. Gold about how GLP-1 medications such as Ozempic and Wegovy are prompting “a reconceptualization of addiction itself” and could help doctors treat alcohol and drug addiction.

This article was originally published on WBUR.org.

Copyright 2026 WBUR
Here & Now Newsroom